Chicago Partners Investment Group’s Niagen Bioscience NAGE Stock Holding History

Chicago Partners Investment Group’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$238K	Buy	74,541 +26,035	+54%	+$106K	﹤0.01%	1356
2026 Q1	$244K	Buy	+48,506	New	+$262K	0.01%	1241
2019 Q3	–	Sell	-15,000	Closed	-$67K	–	340
2019 Q2	$67K	Hold	15,000	–	–	0.01%	316
2019 Q1	$62K	Hold	15,000	–	–	0.01%	308
2018 Q4	$52K	Hold	15,000	–	–	0.01%	312
2018 Q3	$52K	Hold	15,000	–	–	0.01%	512
2018 Q2	$56K	Hold	15,000	–	–	0.01%	467
2018 Q1	$63K	Hold	15,000	–	–	0.01%	418
2017 Q4	$88K	Buy	+15,000	New	+$81K	0.01%	372

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Chicago Partners Investment Group's NAGE Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Niagen Bioscience (NAGE) stake by 54% in Q2 2026, buying an estimated $106K and bringing the position to 74,541 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Chicago Partners Investment Group first reported a position in NAGE in Q4 2017 and has held it in 9 quarters since. The position peaked at $244K in Q1 2026. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Chicago Partners Investment Group held 74,541 shares of Niagen Bioscience worth $238K as of Q2 2026.
Chicago Partners Investment Group bought 26,035 Niagen Bioscience shares in Q2 2026, an estimated $106K.
Niagen Bioscience made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1356 holding.
Chicago Partners Investment Group first reported a position in Niagen Bioscience in Q4 2017 and has held it in 9 quarters since.
Chicago Partners Investment Group's Niagen Bioscience position peaked at $244K in Q1 2026.
139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.